K Janeczek, A Kaczyńska, A Emeryk… - Journal of Asthma and …, 2022 - Taylor & Francis
Bacterial lysates (BLs) are mixtures of bacterial antigens that have been used for many decades to minimize the risk of recurrent respiratory tract infections in both pediatric and …
HS Nelson - The Journal of Allergy and Clinical Immunology: In …, 2024 - Elsevier
Selection of a patient with rhinitis/conjunctivitis or asthma for allergy immunotherapy (AIT) requires several decisions. First, does the patient's sensitization, pattern of exposure to an …
G Tramper‐Stranders, D Ambrożej, A Arcolaci… - Allergy, 2021 - Wiley Online Library
Microbiota composition and associated metabolic activities are essential for the education and development of a healthy immune system. Microbial dysbiosis, caused by risk factors …
Background There are many drugs for allergic rhinitis (AR), however, these drugs show variable clinical effectiveness and some side effects. Therefore, new methods of AR …
F Braido, G Melioli, G Nicolini, M Ferraris… - Drugs in …, 2024 - pmc.ncbi.nlm.nih.gov
This review discusses available evidence on the mechanisms of action of bacterial lysates, and the clinical effects of their sublingual administration. Bacterial lysates act through many …
Background Asthma exacerbations are frequently induced by respiratory tract infections (RTIs). Bacterial lysates have been described to possess immune‐modulatory effects and …
HS Nelson - Allergy & Asthma Proceedings, 2022 - search.ebscohost.com
Background: Orally or sublingually administered lysates of mixed respiratory pathogenic bacteria have been used in Europe, Asia, and other parts of the world, but not the United …
L Zhu, Y Wang, J Feng, Q Zhou - Drug Design, Development and …, 2024 - Taylor & Francis
Background Bacterial lysates are known for having immunomodulatory properties and have been used mainly for the prevention and treatment of respiratory tract infections (RTIs) …